A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys

Phase 2CompletedNCT00520832

Logan College of Chiropractic20 enrolled

Overview

Participants identified as having primary insomnia will be randomly assigned to groups receiving microcurrent stimulation or sham in a double-blind randomized controlled trial. The microcurrent device used is FDA approved for the treatment of insomnia. The hypothesis is that the experimental group will have significantly improved scores on three sleep surveys after treatment while the sham group will not.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Enrollment

Conditions

Primary Insomnia

Interventions

MicrocurrentDEVICE

20 minutes of sub-threshold microcurrent 2 hours before bedtime per day for 21 days.

MicrocurrentDEVICE

Participants will receive a device identical to the active device used in the experimental condition, but which produces no current.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Student, Faculty or Staff * Age 18 - 40 * Symptoms of primary insomnia Exclusion Criteria: * No implanted electric devices * No local infection, injury or malignancy * No history of seizure or other neurological disorders * No current use of prescription or other substances that could effect sleep quality or quantity * Pregnancy

Locations (1)

Logan College of Chiropractic

Chesterfield, Missouri, United States

Outcomes

Primary Outcomes

Pittsburgh Sleep Quality Index (PSQI)

Epworth Sleepiness Scale

Insomnia Severity Index

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.